<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35399111</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling.</ArticleTitle><Pagination><StartPage>328</StartPage><MedlinePgn>328</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">328</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-022-04771-3</ELocationID><Abstract><AbstractText>Brainstem encephalitis, a manifestation of severe enterovirus 71 (EV71) infection, is an acute excessive inflammatory response. The mechanisms underlying its development remain poorly understood. Usually neurotropic viruses trigger acute host immune response by engaging cell surface or intracellular receptors. Here, we show that EV71 engagement with intracellular receptor TLR9 elicits IL-12p40-iNOS signaling causing encephalitis in mice. We identified IL-12p40 to be the only prominent cytokine-induced at the early infection stage in the brainstem of mice subjected to a lethal dose of EV71. The upregulated IL-12p40 proteins were expressed in glial cells but not neuronal cells. To better understand the role of IL-12p40 in severe EV71 infection, we treated the EV71-infected mice with an antibody against IL-12p40 and found the mortality rate, brainstem inflammation, and gliosis to be markedly reduced, suggesting that the acute IL-12p40 response plays a critical role in the pathogenesis of brainstem encephalitis. Mechanistically, intracellular TLR9 was found essential to the activation of the IL-12p40 response. Blocking TLR9 signaling with CpG-ODN antagonist ameliorated IL-12p40 response, brainstem inflammation, and limb paralysis in mice with EV71-induced encephalitis. We further found the glial IL-12p40 response might damage neurons by inducing excess production of neurotoxic NO by iNOS. Overall, EV71 engagement with intracellular TLR9 was found to elicit a neurotoxic glial response via IL12p40-iNOS signaling contributing to the neurological manifestation of EV71 infection. This pathway could potentially be targeted for the treatment of brainstem encephalitis.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lai</LastName><ForeName>Rai-Hua</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chow</LastName><ForeName>Yen-Hung</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan, Taiwan, ROC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Nai-Hsiang</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan, Taiwan, ROC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tsan-Chi</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0001-5221-9707</Identifier><AffiliationInfo><Affiliation>Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shie</LastName><ForeName>Feng-Shiun</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juang</LastName><ForeName>Jyh-Lyh</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-2569-7583</Identifier><AffiliationInfo><Affiliation>Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan, ROC. juang@nhri.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053762">Interleukin-12 Subunit p40</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495370">Tlr9 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051217">Toll-Like Receptor 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="D052247">Nitric Oxide Synthase Type II</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="C496317">Nos2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053762" MajorTopicYN="Y">Interleukin-12 Subunit p40</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052247" MajorTopicYN="N">Nitric Oxide Synthase Type II</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051217" MajorTopicYN="Y">Toll-Like Receptor 9</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>11</Day><Hour>5</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35399111</ArticleId><ArticleId IdType="pmc">PMC8995170</ArticleId><ArticleId IdType="doi">10.1038/s41419-022-04771-3</ArticleId><ArticleId IdType="pii">10.1038/s41419-022-04771-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;90. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;18. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. Enterovirus vaccines for an emerging cause of brain-stem encephalitis. N Engl J Med. 2014;370:792&#x2013;4. doi: 10.1056/NEJMp1400601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1400601</ArticleId><ArticleId IdType="pubmed">24571750</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SL, Pan H, Liu P, Amer S, Chan TC, Zhan J, et al. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol. 2015;25:115&#x2013;28. doi: 10.1002/rmv.1827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1827</ArticleId><ArticleId IdType="pubmed">25704797</ArticleId></ArticleIdList></Reference><Reference><Citation>Long L, Xu L, Xiao Z, Hu S, Luo R, Wang H, et al. Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease. Sci Rep. 2016;6:23444. doi: 10.1038/srep23444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23444</ArticleId><ArticleId IdType="pmc">PMC4802311</ArticleId><ArticleId IdType="pubmed">27001010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin HY, Gau SS, Lu CY, Hsia SH, Huang YC, et al. Enterovirus A71 neurologic complications and long-term sequelae. J Biomed Sci. 2019;26:57. doi: 10.1186/s12929-019-0552-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0552-7</ArticleId><ArticleId IdType="pmc">PMC6688366</ArticleId><ArticleId IdType="pubmed">31395054</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YC, Li XW, Zhu XD, Qian SY, Shang YX, Li BR, et al. Clinical characteristics and treatment of severe encephalitis associated with neurogenic pulmonary edema caused by enterovirus 71 in China. World J Emerg Med. 2010;1:108&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4129752</ArticleId><ArticleId IdType="pubmed">25214951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang PY, Chong CWH, Alonso S. Viral determinants that drive Enterovirus-A71 fitness and virulence. Emerg Microbes Infect. 2021;10:713&#x2013;24. doi: 10.1080/22221751.2021.1906754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1906754</ArticleId><ArticleId IdType="pmc">PMC8043536</ArticleId><ArticleId IdType="pubmed">33745413</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BS, Lee HC, Lee KM, Gong YN, Shih SR. Enterovirus and encephalitis. Front Microbiol. 2020;11:261. doi: 10.3389/fmicb.2020.00261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00261</ArticleId><ArticleId IdType="pmc">PMC7044131</ArticleId><ArticleId IdType="pubmed">32153545</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutelier JP, Van Broeck J, Wolf SF. Interleukin-12 gene expression after viral infection in the mouse. J Virol. 1995;69:1955&#x2013;8. doi: 10.1128/jvi.69.3.1955-1958.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.3.1955-1958.1995</ArticleId><ArticleId IdType="pmc">PMC188815</ArticleId><ArticleId IdType="pubmed">7853541</ArticleId></ArticleIdList></Reference><Reference><Citation>Stobie L, Gurunathan S, Prussin C, Sacks DL, Glaichenhaus N, Wu CY, et al. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci USA. 2000;97:8427&#x2013;32. doi: 10.1073/pnas.160197797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.160197797</ArticleId><ArticleId IdType="pmc">PMC26964</ArticleId><ArticleId IdType="pubmed">10890924</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapil P, Atkinson R, Ramakrishna C, Cua DJ, Bergmann CC, Stohlman SA. Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol. 2009;83:5978&#x2013;86. doi: 10.1128/JVI.00315-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00315-09</ArticleId><ArticleId IdType="pmc">PMC2687402</ArticleId><ArticleId IdType="pubmed">19339350</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916&#x2013;24. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Sluyters RC, Obernier JA. Guidelines for the care and use of mammals in neuroscience and behavioral research. Contemp Top Lab Anim. 2004;43:48&#x2013;+.</Citation></Reference><Reference><Citation>Hung CC, Lin CH, Chang H, Wang CY, Lin SH, Hsu PC, et al. Astrocytic GAP43 induced by the TLR4/NF-kappaB/STAT3 axis attenuates astrogliosis-mediated microglial activation and neurotoxicity. J Neurosci. 2016;36:2027&#x2013;43. doi: 10.1523/JNEUROSCI.3457-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3457-15.2016</ArticleId><ArticleId IdType="pmc">PMC6602016</ArticleId><ArticleId IdType="pubmed">26865625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Lin CH, Hsu PC, Sun YY, Huang YJ, Zhuo JH, et al. Aryl hydrocarbon receptor mediates both proinflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia. Glia. 2015;63:1138&#x2013;54. doi: 10.1002/glia.22805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22805</ArticleId><ArticleId IdType="pubmed">25690886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Yu SL, Shao HY, Lin HY, Liu CC, Hsiao KN, et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS One. 2013;8:e57591. doi: 10.1371/journal.pone.0057591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Cao S, Kim S, Chung EY, Homma Y, Guan X, et al. Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression. Curr Immunol Rev. 2005;1:119&#x2013;37. doi: 10.2174/1573395054065115.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573395054065115</ArticleId><ArticleId IdType="pmc">PMC2965603</ArticleId><ArticleId IdType="pubmed">21037949</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S, Kundu M, Jana M, Roy A, Rangasamy SB, Modi KK, et al. IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rbeta1 internalization and suppress EAE. Proc Natl Acad Sci USA. 2020;117:21557&#x2013;67. doi: 10.1073/pnas.2000653117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2000653117</ArticleId><ArticleId IdType="pmc">PMC7474649</ArticleId><ArticleId IdType="pubmed">32817415</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng M, Guo S, Fan S, Zeng X, Zhang Y, Liao Y, et al. The preferential infection of astrocytes by enterovirus 71 plays a key role in the viral neurogenic pathogenesis. Front Cell Infect Microbiol. 2016;6:192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5174126</ArticleId><ArticleId IdType="pubmed">28066727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 2002;91:632&#x2013;5. doi: 10.1111/j.1651-2227.2002.tb03292.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2002.tb03292.x</ArticleId><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Yu CK. Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci. 2014;21:31. doi: 10.1186/1423-0127-21-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-31</ArticleId><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S. Cellular receptors for enterovirus A71. J Biomed Sci. 2020;27:23. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461. doi: 10.3389/fimmu.2014.00461.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00461</ArticleId><ArticleId IdType="pmc">PMC4174766</ArticleId><ArticleId IdType="pubmed">25309543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Lu MY, Chuang CF, Kuo Y, Lin HE, Li FA, et al. TLR7 is critical for anti-viral humoral immunity to EV71. Front Immunol. 2020;11:614743. doi: 10.3389/fimmu.2020.614743.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.614743</ArticleId><ArticleId IdType="pmc">PMC7935532</ArticleId><ArticleId IdType="pubmed">33679702</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor DL, Zhong L, Begg DJ, de Silva K, Whittington RJ. Toll-like receptor genes are differentially expressed at the sites of infection during the progression of Johne&#x2019;s disease in outbred sheep. Vet Immunol Immunopathol. 2008;124:132&#x2013;51. doi: 10.1016/j.vetimm.2008.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2008.02.021</ArticleId><ArticleId IdType="pubmed">18403023</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 2002;169:3155&#x2013;62. doi: 10.4049/jimmunol.169.6.3155.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.6.3155</ArticleId><ArticleId IdType="pubmed">12218133</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghan-Manshadi M, Hadinedoushan H, Amirbaigy MK, Zare F, Eslami G, Mirghanizade-Bafghi SA, et al. Relative expression of toll-like receptors 2 and 7 mRNA in peripheral blood of patients with hepatitis C. Hepat Mon. 2015;15:e30427. doi: 10.5812/hepatmon.30427.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/hepatmon.30427</ArticleId><ArticleId IdType="pmc">PMC4719121</ArticleId><ArticleId IdType="pubmed">26834788</ArticleId></ArticleIdList></Reference><Reference><Citation>Goriely S, Molle C, Nguyen M, Albarani V, Haddou NO, Lin R, et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood. 2006;107:1078&#x2013;84. doi: 10.1182/blood-2005-06-2416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-06-2416</ArticleId><ArticleId IdType="pubmed">16219795</ArticleId></ArticleIdList></Reference><Reference><Citation>Koshiba R, Yanai H, Matsuda A, Goto A, Nakajima A, Negishi H, et al. Regulation of cooperative function of the Il12b enhancer and promoter by the interferon regulatory factors 3 and 5. Biochem Biophys Res Commun. 2013;430:95&#x2013;100. doi: 10.1016/j.bbrc.2012.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.11.006</ArticleId><ArticleId IdType="pubmed">23154183</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahan K, Sheikh FG, Liu X, Hilger S, McKinney M, Petro TM. Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J Biol Chem. 2001;276:7899&#x2013;905. doi: 10.1074/jbc.M008262200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M008262200</ArticleId><ArticleId IdType="pmc">PMC2041874</ArticleId><ArticleId IdType="pubmed">11110796</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii S, Akaike T, Maeda H. Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology. 1999;256:203&#x2013;12. doi: 10.1006/viro.1999.9610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.9610</ArticleId><ArticleId IdType="pubmed">10191185</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Collazo E, Avendano-Ortiz J, Martin-Quiros A, Aguirre LA. Immune response and COVID-19: a mirror image of Sepsis. Int J Biol Sci. 2020;16:2479&#x2013;89. doi: 10.7150/ijbs.48400.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.48400</ArticleId><ArticleId IdType="pmc">PMC7415424</ArticleId><ArticleId IdType="pubmed">32792851</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92:552&#x2013;5. doi: 10.1002/jmv.25728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70:311&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329044</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger JR. COVID-19 and the nervous system. J Neurovirol. 2020;26:143&#x2013;8. doi: 10.1007/s13365-020-00840-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00840-5</ArticleId><ArticleId IdType="pmc">PMC7245181</ArticleId><ArticleId IdType="pubmed">32447630</ArticleId></ArticleIdList></Reference><Reference><Citation>Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodriguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62&#x2013;75. doi: 10.1016/j.cytogfr.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7265853</ArticleId><ArticleId IdType="pubmed">32513566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjan LH, Furukawa K, Nagano T, Kiriu T, Nishimura M, Arii J, et al. Early differences in cytokine production by severity of coronavirus disease 2019. J Infect Dis. 2021;223:1145&#x2013;9. doi: 10.1093/infdis/jiab005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab005</ArticleId><ArticleId IdType="pmc">PMC7928883</ArticleId><ArticleId IdType="pubmed">33411935</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezemer GFG, Garssen J. TLR9 and COVID-19: a multidisciplinary theory of a multifaceted therapeutic target. Front Pharm. 2020;11:601685. doi: 10.3389/fphar.2020.601685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.601685</ArticleId><ArticleId IdType="pmc">PMC7844586</ArticleId><ArticleId IdType="pubmed">33519463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740&#x2013;5. doi: 10.1038/35047123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35047123</ArticleId><ArticleId IdType="pubmed">11130078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai JH, Wang MY, Huang CY, Wu CH, Hung LF, Yang CY, et al. Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells. EMBO Rep. 2018;19:e46182. doi: 10.15252/embr.201846182.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201846182</ArticleId><ArticleId IdType="pmc">PMC6073071</ArticleId><ArticleId IdType="pubmed">29880709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasidharan A, Hassan WM, Harrison CJ, Hassan F, Selvarangan R. Host immune response to enterovirus and parechovirus systemic infections in children. Open Forum Infect Dis. 2020;7:ofaa261. doi: 10.1093/ofid/ofaa261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa261</ArticleId><ArticleId IdType="pmc">PMC7443103</ArticleId><ArticleId IdType="pubmed">32855983</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SZ, Bao YX, Rosenberger CL, Tesfaigzi Y, Stark JM, Harrod KS. IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection. J Immunol. 2004;173:4040&#x2013;9. doi: 10.4049/jimmunol.173.6.4040.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.6.4040</ArticleId><ArticleId IdType="pubmed">15356153</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegemann-Koniszewski S, Behrens S, Boehme JD, Hochnadel I, Riese P, Guzman CA, et al. Respiratory influenza A virus infection triggers local and systemic natural killer cell activation via toll-like receptor 7. Front Immunol. 2018;9:245. doi: 10.3389/fimmu.2018.00245.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00245</ArticleId><ArticleId IdType="pmc">PMC5819576</ArticleId><ArticleId IdType="pubmed">29497422</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana M, Dasgupta S, Pal U, Pahan K. IL-12 p40 homodimer, the so-called biologically inactive molecule, induces nitric oxide synthase in microglia via IL-12R beta 1. Glia. 2009;57:1553&#x2013;65. doi: 10.1002/glia.20869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20869</ArticleId><ArticleId IdType="pmc">PMC2744843</ArticleId><ArticleId IdType="pubmed">19306359</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>